Skip to main content

Table 1 Comparison of the baseline characteristics between the two groups

From: A nonrandomized controlled trial of individualized exercise prescription combined with remote exercise management in patients who are overweight or obese

 

Experimental group (n = 55)

Before intervention

Control group (n = 34)

Before intervention

t

P

Weight (kg)

78.54 ± 12.58

75.29 ± 12.71

−1.180

0.241

BMI (kg/m2)

27.86 ± 3.17

27.59 ± 2.81

−0.399

0.691

WC (cm)

89.27 ± 7.85

88.66 ± 9.12

−0.355

0.738

HC (cm)

101.36 ± 5.73

101.19 ± 6.89

−0.128

0.899

SBP (mmHg)

127.20 ± 16.60

124.85 ± 15.50

−0.664

0.504

DBP(mmHg)

77.13 ± 10.78

76.97 ± 13.28

−0.061

0.952

VC (cm2)

83.31 ± 32.82

80.43 ± 33.49

−0.399

0.691

BF (kg)

26.39 ± 6.45

26.78 ± 5.04

0.299

0.706

SMC (kg)

28.99 ± 6.27

27.11 ± 6.28

−1.380

0.171

BF (%)

33.55 ± 6.34

35.61 ± 5.14

1.594

0.114

UA (µmol/L)

361.96 ± 96.55

322.12 ± 90.45

−1.937

0.056

TC (mmol/L)

4.52 ± 0.71

4.76 ± 0.81

1.495

0.139

TG (mmol/L)

1.37 ± 0.65

1.57 ± 1.42

0.919

0.361

LDL-C (mmol/L)

1.20 ± 0.19

1.29 ± 0.21

1.865

0.066

HDL-C (mmol/L)

2.77 ± 0.67

2.87 ± 0.66

0.752

0.454

HbA1c (%)

5.60 ± 0.45

5.58 ± 0.38

−0.184

0.855

FBG (mmol/L)

5.21 ± 0.62

5.07 ± 0.47

−1.129

0.262

FI (μU/mL)

11.16 ± 5.34

11.45 ± 5.52

0.247

0.805

HOMA-IR

2.59 ± 1.40

2.58 ± 1.25

−0.027

0.978

  1. WC waist circumference, HC hip circumference, SBP systolic blood pressure, DBP diastolic blood pressure, VFA visceral fat area, BF body fat, SMC skeletal muscle content, UA uric acid, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, HbA1c hemoglobin A1c, FBG fasting blood glucose, FI fasting insulin, HOMA-IR homeostatic model assessment of insulin resistance